Dr. Reddy’s Laboratories Ltd announced today the commercilazation of Vozet Tablets in India, indicated for the treatment of allergic Rhinitis and chronic Urticaria.
The Vozet Tablets contain Levocetirizine 5 mg, and are available in a strip size of 10.
The anti-histamine market in India had sales of INR 1038cr MAT for the most recent twelve months ended in March 2017, according to IMS ORG. Dr. Reddy’s will further strengthen its anti-allergy portfolio with the addition of Vozet.
CXOTV DAILY NEWS CAPSULE | Tuesday | 11th May’21
May 12, 2021
CXOTV DAILY NEWS CAPSULE | Monday | 10th May’21
May 10, 2021
CXOTV DAILY NEWS CAPSULE | Friday | 7th May’21
May 7, 2021
CXOTV DAILY NEWS CAPSULE | Wednesday | 5th May’21
May 5, 2021
Demystifying Zero Trust and SASE | Sachin Jain & Kalpana Singhal
April 14, 2021
AI-ML, Blockchain Help Banks Check Digital Transaction Frauds
April 13, 2021
WiMi Unveils Cutting-Edge Multi-Objective 3D Modeling and Reconstruction System
September 1, 2023
Shenzhen and Hong Kong Join Forces to Establish a Cutting-Edge Research Hub
September 1, 2023
September 1, 2023
September 1, 2023
IFS Announces Acquisition of Falkonry AI, Expanding its AI Capabilities
September 1, 2023
August 30, 2023
August 30, 2023
Singapore and Vietnam Strengthen Collaboration in New and Emerging Sectors
August 30, 2023
August 30, 2023
MGBF Takes Center Stage in Economic Development, Policy Analysis, and Investment Promotions
August 30, 2023
APAC’s first and one-of-a-kind news capsule,CXOTV.news exclusively provides all relevant IT industry reports and information to you in quick bytes.
TECHPLUS MEDIA PTE LTD.
68 Circular Road
02-01 Singapore – 049422
Contact : +65 94278359/ 81505361
Sales : sales.apac@cxotv.news
Editorials – content.apac@cxotv.new
© 2023 All Rights Reserved. Techplus Media PTE Ltd.
